Sept. 2, 2021 — Over the past decade, advances in HIV treatment have yielded new drug combinations, once-daily dosing, and, most recently, the introduction of long-acting injectables for pre- and post-exposure prevention and treatment. But why has it been so difficult to make an HIV vaccine? “The difficulties of vaccine candidates that have … Read more
Secondly, the FDA has yet to greenlight any of these treatments. What’s more, some early trials of mRNA therapies have suffered major stumbling blocks on the road to market approval. In January, CureVac reported disappointing results in a clinical trial of its new mRNA-based drug for prostate cancer. The company’s CV9014 drug did … Read more
A group of developing countries, backed by United Nations agencies and activist groups, is pushing to limit patent protections for Covid-19 vaccines being tested by some of the world’s biggest pharmaceutical companies so that inexpensive copies can be produced for poorer nations. South Africa, Ghana, Senegal, Pakistan and others argue they won’t be able to … Read more